High-dose Bevacizumab in Advanced Renal Carcinoma Patients

Clinical trial NCT00455975 · COMPLETED

Trial details

NCT number: NCT00455975
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cancer Kidney Cancer

Start date: 2007-02-01
Primary completion: 2013-07-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.